BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 796810)

  • 1. [Von Willebrand factor activity and thrombophilic states. A review (author's transl)].
    Boneu B; Abbal M; Barret A; Fournie A; Bierme R
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():48-53. PubMed ID: 796810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
    Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM
    Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in women with different types of von Willebrand disease.
    Conti M; Mari D; Conti E; Muggiasca ML; Mannucci PM
    Obstet Gynecol; 1986 Aug; 68(2):282-5. PubMed ID: 3090493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation and fibrinolysis in human pregnancy.
    Bonnar J
    Bibl Anat; 1973; 12():58-63. PubMed ID: 4790392
    [No Abstract]   [Full Text] [Related]  

  • 7. Von Willebrand factor, diabetes mellitus and retinopathy.
    Paton RC; Passa P; Canivet J
    Horm Metab Res Suppl; 1981; 11():55-8. PubMed ID: 6797913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening method of determining the activity of the Willebrand factor].
    Smolianitskiĭ AIa; Iakunin GA
    Lab Delo; 1983; (4):48-50. PubMed ID: 6191085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrophoretic properties of the factor VIII/vW complex in liver disease (author's transl)].
    Vicente García VU; Alberca Silva I; Moraleda Jiménez JM; López Borrasca A
    Sangre (Barc); 1980; 25(4):471-8. PubMed ID: 6775380
    [No Abstract]   [Full Text] [Related]  

  • 10. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage?
    Giustolisi R; Musso R; Cacciola E; Cacciola RR; Russo M; Petralito A
    Thromb Haemost; 1984 Jul; 51(3):408. PubMed ID: 6437008
    [No Abstract]   [Full Text] [Related]  

  • 15. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of von Willebrand factor in pre-eclampsia.
    Bergmann F; Rotmensch S; Rosenzweig B; How H; Chediak J
    Thromb Haemost; 1991 Nov; 66(5):525-8. PubMed ID: 1803615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia.
    Deng L; Bremme K; Hansson LO; Blombäck M
    Obstet Gynecol; 1994 Dec; 84(6):941-5. PubMed ID: 7970473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factor VIII (von Willebrand antigen) in patients with acquired thrombocytopathies].
    Genova V; Baleva M; Nikolov K
    Vutr Boles; 1987; 26(2):82-5. PubMed ID: 3111097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII procoagulant antigen levels in normal pregnancy and preeclampsia.
    Lazarchick J; Stubbs TM; Romein LA
    Ann Clin Lab Sci; 1986; 16(5):395-8. PubMed ID: 3096191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.